
Managing Partner, Union Square Ventures
USV managing partner backing network-driven startups
Rebecca Kaden is a Managing Partner at Union Square Ventures, where she joined in 2017 and became the firm's first female partner. She started her career as a journalist and previously served as a General Partner at Maveron, a consumer-focused early-stage fund. At USV she leads investments aligned with the firm's thesis around networks, platforms, and enabling technologies. Her notable deals include Modern Fertility and companies in women's health and consumer tech. She holds an MBA from Stanford and studied English and American Literature at Harvard. She is based in New York City.
Backs companies that use networks and platforms to shift control to individuals, challenge incumbents, and unlock new data access—thesis-driven investing in markets undergoing structural change.
Typical check: $1M–$20M
Based in: New York, NY, USA (North America)
Modern Fertility
Women's at-home hormone testing; USV investment led by Kaden
Slope
AI-powered B2B payments platform; USV Series A & follow-on 2023
Teamshares
Employee ownership platform for small businesses; USV every round
Journey Clinical
Psychedelic-assisted therapy platform; USV Series A 2023
Allbirds
DTC footwear brand; invested while at Maveron pre-USV
Earnest
Student loan refinancing fintech; invested at Maveron
Dia & Co
Plus-size fashion marketplace; invested at Maveron